Serum concentrations of fibroblast growth factor 2 are increased in HIV type 1-infected patients and inversely related to survival probability

AIDS Research and Human Retroviruses

Volumn 17, Issue 11, 2001, Pages 1035-1039

  Ascherl, Gudrun ^a   Sturzl, Michael ^a   Sgadari, Cecilia ^b   Bugarini, Roberto ^b   Ensoli, Barbara ^b   Bogner, Johannes ^c   Schatz, Oktavian ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; FIBROBLAST GROWTH FACTOR 2; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DISEASE MARKER; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK; SKIN; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR LOCALIZATION; VASCULAR DISEASE; VISCERA;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SARCOMA, KAPOSI; SKIN NEOPLASMS;

EID: 0034827715     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201300343717     Document Type: Article

References (30)

1. HIV-related ocular microangiopathic syndrome cognitive functioning
2. Acquired immune deficiency syndrome. Ocular manifestations
3. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: Immunohistochemical localization of serum proteins in postmortem brain
4. Kaposi's sarcoma: A result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
5. Aortic endothelium in HIV-1 infection: Chronic injury, activation, and increased leukocyte adherence
6. Angiogenic factors
7. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects
8. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
9. Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization
10. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability lesion development
11. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma
12. Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma: Clinical, histological and cell biological evaluation
13. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice
14. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice
15. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: A potential pathologic role
16. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: Differential production and release by CD4+ and CD8+ T cells
17. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells
18. Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells
19. The inhibition of fibroblast growth factor-2 export by cardenolides implies a novel function for the catalytic subunit of Na+, K+-ATPase
20. Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis
21. Idiopathic production of interleukin-1 in acquired immune deficiency syndrome
22. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome
23. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases
24. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis, and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin
25. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor
26. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers
27. Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas
28. A high pretreatment serum basic fibroblast growth factor concentration is an independent predictor of poor prognosis in non-Hodgkin's lymphoma
29. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium
30. Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: Implications for acquired immunodeficiency syndrome-associated vasculopathy